Literature DB >> 17987279

Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia.

Stephanie K Geiger1, Harald Bär, Philipp Ehlermann, Sarah Wälde, Désirée Rutschow, Raphael Zeller, Boris T Ivandic, Hanswalter Zentgraf, Hugo A Katus, Harald Herrmann, Dieter Weichenhan.   

Abstract

We have identified a family in which several members died of sudden cardiac death or suffer from dilated cardiomyopathy (DCM) and rhythm disturbances. Mutation screening revealed co-segregation of a novel nonsense mutation (pR321X) in the lamin A gene, LMNA, with the disease. Lamin A, and its smaller splice form lamin C are nuclear intermediate filament proteins forming a major part of the lamina, which is underlying the inner nuclear membrane. They are involved in the organization of heterochromatin and both in DNA replication and transcription. Recently, an increasing number of missense mutations in LMNA have been discovered to cause various types of rare diseases. Here, we investigated the causal role of the new nonsense mutation for the disease. Quantification of wild type and mutant lamin A mRNA from explanted myocardial tissue and cultured fibroblasts revealed an up to 30-fold reduction in the relative amount of the mutant transcript indicating that its synthesis was massively down-regulated by nonsense-mediated mRNA decay (NMD). Correspondingly, we did not detect the mutant truncated lamin A by Western blot analysis in extracts of patient fibroblasts and cardiac muscle tissue. Both wild type lamin A and C were present, however, in normal quantities. The immunohistochemical analyses of patient tissues revealed a normal distribution of lamin A/C and of major inner nuclear membrane proteins such as emerin and the lamin B receptor. Moreover, both chromatin distribution and nuclear shape were normal. However, over-expression of truncated lamin A in HeLa cells by transient transfection caused major disturbances of lamin A organization within both the nucleoplasm and the cytoplasm. In addition, after treatment of patient fibroblasts with the proteasome inhibitor epoxomicin, mutant truncated lamin A was detected in relatively high levels by Western blotting demonstrating that it is synthesized in these cells. Therefore, we conclude that NMD is not sufficient to completely prevent the expression of truncated lamin A and that even trace amounts of it may negatively interfere with structural and/or regulatory functions of lamin A/C eventually leading to the development of DCM and rhythm disturbances.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17987279     DOI: 10.1007/s00109-007-0275-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  21 in total

Review 1.  Nonsense-mediated mRNA decay in mammals.

Authors:  Lynne E Maquat
Journal:  J Cell Sci       Date:  2005-05-01       Impact factor: 5.285

Review 2.  A-type lamin complexes and regenerative potential: a step towards understanding laminopathic diseases?

Authors:  Josef Gotzmann; Roland Foisner
Journal:  Histochem Cell Biol       Date:  2005-09-02       Impact factor: 4.304

Review 3.  Nuclear lamins, diseases and aging.

Authors:  Anna Mattout; Thomas Dechat; Stephen A Adam; Robert D Goldman; Yosef Gruenbaum
Journal:  Curr Opin Cell Biol       Date:  2006-04-24       Impact factor: 8.382

4.  Proteasome-mediated degradation of integral inner nuclear membrane protein emerin in fibroblasts lacking A-type lamins.

Authors:  Antoine Muchir; Catherine Massart; Baziel G van Engelen; Martin Lammens; Gisèle Bonne; Howard J Worman
Journal:  Biochem Biophys Res Commun       Date:  2006-11-03       Impact factor: 3.575

Review 5.  Nuclear lamins: laminopathies and their role in premature ageing.

Authors:  J L V Broers; F C S Ramaekers; G Bonne; R Ben Yaou; C J Hutchison
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

Review 6.  A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance.

Authors:  E Nagy; L E Maquat
Journal:  Trends Biochem Sci       Date:  1998-06       Impact factor: 13.807

7.  Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE.

Authors:  Raphael Zeller; Boris T Ivandic; Philipp Ehlermann; Oliver Mücke; Christian Zugck; Andrew Remppis; Evangelos Giannitsis; Hugo A Katus; Dieter Weichenhan
Journal:  J Mol Med (Berl)       Date:  2006-05-20       Impact factor: 4.599

8.  Native chick laminin-4 containing the beta 2 chain (s-laminin) promotes motor axon growth.

Authors:  R Brandenberger; R A Kammerer; J Engel; M Chiquet
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

9.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Investigation of nuclear architecture with a domain-presenting expression system.

Authors:  Christine K Dreger; Alexandra R König; Herbert Spring; Peter Lichter; Harald Herrmann
Journal:  J Struct Biol       Date:  2002 Oct-Dec       Impact factor: 2.867

View more
  17 in total

1.  Lamin B receptor regulates the growth and maturation of myeloid progenitors via its sterol reductase domain: implications for cholesterol biosynthesis in regulating myelopoiesis.

Authors:  Gayathri Subramanian; Pulkit Chaudhury; Krishnakumar Malu; Samantha Fowler; Rahul Manmode; Deepali Gotur; Monika Zwerger; David Ryan; Rita Roberti; Peter Gaines
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Altering lamina assembly reveals lamina-dependent and -independent functions for A-type lamins.

Authors:  Monika Zwerger; Heidi Roschitzki-Voser; Reto Zbinden; Celine Denais; Harald Herrmann; Jan Lammerding; Markus G Grütter; Ohad Medalia
Journal:  J Cell Sci       Date:  2015-08-14       Impact factor: 5.285

3.  The laminated hearts.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2008-01-15       Impact factor: 4.599

4.  Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels.

Authors:  Siyong Teng; Lizhi Gao; Vesa Paajanen; Jielin Pu; Zheng Fan
Journal:  Cardiovasc Res       Date:  2009-04-17       Impact factor: 10.787

Review 5.  The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.

Authors:  Lucie Carrier; Saskia Schlossarek; Monte S Willis; Thomas Eschenhagen
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

6.  An absence of nuclear lamins in keratinocytes leads to ichthyosis, defective epidermal barrier function, and intrusion of nuclear membranes and endoplasmic reticulum into the nuclear chromatin.

Authors:  Hea-Jin Jung; Angelica Tatar; Yiping Tu; Chika Nobumori; Shao H Yang; Chris N Goulbourne; Harald Herrmann; Loren G Fong; Stephen G Young
Journal:  Mol Cell Biol       Date:  2014-10-13       Impact factor: 4.272

Review 7.  Nonsense-mediated decay in genetic disease: friend or foe?

Authors:  Jake N Miller; David A Pearce
Journal:  Mutat Res Rev Mutat Res       Date:  2014-05-28       Impact factor: 5.657

8.  Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling.

Authors:  Monika Zwerger; Diana E Jaalouk; Maria L Lombardi; Philipp Isermann; Monika Mauermann; George Dialynas; Harald Herrmann; Lori L Wallrath; Jan Lammerding
Journal:  Hum Mol Genet       Date:  2013-02-19       Impact factor: 6.150

Review 9.  Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.

Authors:  Amelia A Glazier; Andrea Thompson; Sharlene M Day
Journal:  Pflugers Arch       Date:  2018-11-20       Impact factor: 3.657

10.  Induction of a massive endoplasmic reticulum and perinuclear space expansion by expression of lamin B receptor mutants and the related sterol reductases TM7SF2 and DHCR7.

Authors:  Monika Zwerger; Thorsten Kolb; Karsten Richter; Iakowos Karakesisoglou; Harald Herrmann
Journal:  Mol Biol Cell       Date:  2009-11-25       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.